| |
|
|
|
|
|
|
|||
|
Blood, 15 May 2008, Vol. 111, No. 10, pp. 5037-5046. Prepublished online as a Blood First Edition Paper on March 12, 2008; DOI 10.1182/blood-2007-07-099549.
Submitted July 6, 2007
Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden * Corresponding author; email: smed-sorensen.anna{at}gene.com.
Dendritic cells (DCs) process and present bacterial and endogenous lipid antigens in complex with CD1 molecules to T cells and invariant NKT cells. However, different types of DCs, such as blood myeloid DCs and skin Langerhans cells exhibit distinct patterns of CD1a, CD1b, CD1c and CD1d expression. The regulation of such differences is incompletely understood. Here, we initially observed that monocyte-derived DCs cultured in an immunoglobulin-rich milieu expressed CD1d but not CD1a, CD1b and CD1c, whereas DCs cultured in the presence of low levels of immunoglobulins had an opposite CD1 profile. Based on this, we tested the possibility that immunoglobulins play a central role in determining these differences in DCs developing from monocytes. IgG-depletion and IVIg add-in experiments strongly supported a role for IgG in directing the CD1 expression profile. Blocking experiments indicated that this effect was mediated by Fc
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||